Form 4: Prestige Consumer Healthcare Exec Trades Shares

Ronald M. Lombardi, CEO and Director of Prestige Consumer Healthcare Inc., reported a transaction involving the acquisition of common stock.

Summary

• Ronald M. Lombardi, Chief Executive Officer and Director of Prestige Consumer Healthcare Inc. (PBH), reported a transaction on May 5, 2026.
• The transaction involved the acquisition of 2,197 shares of common stock at a price of $55.75 per share.
• Following this transaction, Mr. Lombardi beneficially owns 376,008 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents an insider acquisition of stock, which can signal confidence, but does not provide new financial performance data.

Positives

• The CEO and Director acquired additional shares, indicating confidence in the company.
• The acquisition was made at a specific price point, suggesting a planned investment rather than a market reaction.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider transactions, particularly acquisitions by senior management, are often viewed by the market as a signal of confidence in the company's future prospects.

Stakeholder Impact

• Shareholders may view this acquisition positively as a sign of management confidence.
• Employees may be encouraged by leadership's investment in the company's stock.
• Creditors and suppliers are unlikely to be directly impacted by this individual stock transaction.

Key Dates

Keywords

Prestige Consumer Healthcare, PBH, Form 4, Insider Trading, Stock Transaction, CEO, Director, Common Stock